Table 1.

Studies Reporting >10 Cases of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Received a Diagnosis of Mucormycosis

Study	Type of Study	No. of Patients/Study Period	Outcome
Marr, single institution 2002 [23]	Retrospective	29/1985–1999	Median survival: 66 day 1-year survival rate: 20%
Roden, literature review 2005 [4]	Retrospective	44/1940–2003	Mortality rate: 91%
Kontoyiannis, single institution 2005 [24]	Prospective	13/2002–2004	Unreported for specific subpopulations
Trifilio, multicentric case series 2007 [25]	Retrospective	34/2002–2005	Mortality rate: 64%
Chamilos, single institution 2008 [5]	Retrospective	32/1989–2006	Mortality rate: 56%
Bitar, national hospital discharge codes 2009 [7]	Retrospective	33a/1997–2006	Mortality rate: 36.4%
Neofytos, active surveillance 2009 [26]	Prospective	12/2004–2007	12-week mortality rate: 64.3%b
Kontoyiannis, active surveillance 2010 [6]	Prospective	77a/2001–2006	1-year overall survival rate: 28%
Rüping, passive surveillance 2010 [20]	Prospective	12/2006–2009	Mortality rate: 75%
Skiada, passive surveillance 2011 [1]	Prospective	21/2005–2007	Mortality rate: 76%

^aIncluding patients with autologous transplantation.

^bFor 12 allogeneic transplant recipients and 6 autologous transplant recipients.